Showing results (821-830 of 1,030) with videos related to

Sort By:
Pageof 103
Plos One|January 10, 2013
PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sitesJürgen Glas, Julia Seiderer, Darina Czamara, et al.
Environmental Science & Technology|December 20, 2022
Expiratory Aerosol pH: The Overlooked Driver of Airborne Virus InactivationBeiping Luo, Aline Schaub, Irina Glas, et al.
Nature Communications|June 24, 2021
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progressionI-Na Lu, Celia Dobersalske, Laurèl Rauschenbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trialG Viale, L Slaets, J Bogaerts, et al.
Breast Cancer Research and Treatment|February 14, 2009
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancerMarieke E Straver, Annuska M Glas, Juliane Hannemann, et al.
The British Journal of Surgery|April 8, 2020
Effect of omission of surgery on survival in patients aged 80 years and older with early-stage hormone receptor-positive breast cancerA Z de Boer, N A de Glas, P J Marang-van de Mheen, et al.
Fundamental & Clinical Pharmacology|February 19, 2025
Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild typeEdwin Brokaar, Jonathan Knikman, Loes Visser, et al.
European Journal of Immunology|March 27, 2021
Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test developmentPavlo Holenya, Paul Joris Lange, Ulf Reimer, et al.
Journal of Cancer Research and Clinical Oncology|April 22, 2016
Phase I trial of dovitinib (TKI258) in recurrent glioblastomaNiklas Schäfer, Gerrit H Gielen, Sied Kebir, et al.
Cancers|December 24, 2021
Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic ReviewJoosje C Baltussen, Marij J P Welters, Elizabeth M E Verdegaal, et al.
Pageof 103